Skip to main content
Finolex Industries Ltd. logo

Finolex Industries Ltd. — Investor Relations & Filings

Ticker · FINPIPE ISIN · INE183A01024 LEI · 335800DLFD2ERNKIDE17 BSE.NS Manufacturing
Open in API
Filings indexed 1,864 across all filing types
Latest filing 2023-02-14 Regulatory Filings
Country IN India
Listing BSE.NS FINPIPE

About Finolex Industries Ltd.

https://www.finolexpipes.com/

Finolex Industries Ltd. is a manufacturer of polyvinyl chloride (PVC) pipes and fittings, as well as PVC resin. The company operates a backward-integrated manufacturing model, producing its own PVC resin to ensure quality control and supply consistency for its downstream pipe production. Its product portfolio includes a comprehensive range of PVC-U pipes and fittings designed for applications in agriculture, plumbing, and sanitation. These products support irrigation systems, borewells, and residential and commercial water management. With multiple manufacturing facilities and an extensive distribution network, the company provides fluid management solutions across various sectors. It is characterized by its focus on high-quality standards and technological integration, offering durable products for water transportation and infrastructure development.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated 14th February 2023 addressed to stock exchanges regarding an upcoming Analyst/Investor meeting with the company's senior management. It references Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of events or information. The content is an intimation about a scheduled investor interaction, not a detailed financial report, earnings release, or presentation. The document length is only 1387 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under the category of Investor Presentation (IP) or Regulatory Filings (RNS). However, since it is only an intimation of a meeting and not the presentation itself, it is more appropriate to classify it as Regulatory Filings (RNS), which covers general regulatory announcements and disclosures that do not fit other categories.
2023-02-14 English
Intimation of Analyst/Investors meet/ Interaction scheduled on February 14, 2023
Investor Presentation Classification · 90% confidence The document is a short notice dated 14th February 2023 addressed to stock exchanges about an upcoming Analyst/Investor meeting with the company's senior management. It references Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of events or information. The content is an intimation about a scheduled investor interaction, not a detailed financial report or transcript. The document length is only 1387 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits the category of Investor Presentation (IP) or possibly a Regulatory Filing (RNS). However, since it specifically announces an investor meeting, the best fit is Investor Presentation (IP).
2023-02-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short communication dated 11th February 2023 addressed to stock exchanges regarding the outcome of an investors/analysts meeting held on 10th February 2023. It explicitly states that no presentation or unpublished price sensitive information was discussed, only a company overview. The document is brief (1779 characters) and serves as a notification of the meeting outcome rather than containing detailed financial data or a full transcript. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. This type of document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement without substantive financial or management report content.
2023-02-11 English
Outcome of investors/analysts meeting held on 10th February, 2023
Regulatory Filings Classification · 95% confidence The document is a short communication (1779 characters) addressed to stock exchanges regarding the outcome of an investors/analysts meeting held on 10th February 2023. It explicitly states that no presentation or unpublished price sensitive information was discussed, only a company overview. The document is a notification of the meeting outcome rather than a detailed report or transcript. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. Given the brevity and nature of the document, it is not a full investor presentation or call transcript but an announcement about the meeting outcome. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-02-11 English
This is further to our letter no. FIL/SEC/SEs/2022-23/093 and in terms of the subject referred regulation, we hereby submit transcript of earnings call held on 6th February, 2023, for discussing ....
Call Transcript Classification · 100% confidence The document is a transcript of an earnings conference call for Finolex Industries Limited discussing Q3 FY2023 financial results. It includes detailed management commentary on financial performance, segmental results, volumes, and outlook, as well as a Q&A session with analysts. The presence of a full transcript of the call, including management remarks and analyst questions, clearly identifies this as a Call Transcript (CT). The document references the quarter and nine months ended December 31, 2022, and contains substantive financial discussion, consistent with an earnings call transcript. It is not a brief earnings release or a report publication announcement, but a full transcript of the call.
2023-02-10 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of an earnings conference call for Finolex Industries Limited discussing Q3 FY2023 financial results. It includes detailed management commentary on financial performance, segmental results, volumes, and outlook, as well as a Q&A session with analysts. The presence of a full transcript of the call, including management and analyst dialogue, clearly identifies this as a Call Transcript (CT). The document references the quarter and nine months ended December 31, 2022, and contains substantive financial discussion, consistent with an earnings call transcript. It is not a brief earnings release, annual report, or other filing type. Therefore, the correct classification is Call Transcript (CT).
2023-02-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.